Compound Detail
CHEMBL5095451
ETRANACOGENE DEZAPARVOVEC 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL5095451 |
| Name | ETRANACOGENE DEZAPARVOVEC |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
5
Known Names
2
Indications
1
Mechanisms
Drug Information
| Molecule Type | Gene |
| First Approval | 2023 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Coagulation factor IX exogenous protein | EXOGENOUS PROTEIN | Coagulation factor IX | ✓ | ✓ |
Indications
Hemophilia B Hemorrhage
ATC Classification
B02BD16
etranacogene dezaparvovec
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTIHEMORRHAGICS
Data from ChEMBL 36 via Core Engine